NoMo Diagnostics on path to becoming the first FDA approved concussion detector

“Traumatic brain injuries and concussions contribute to nearly 50,000 deaths in the United States annually, according to the Centers for Disease Control & Prevention. Many of those injuries are never diagnosed or are recognized too late. It's a hot-button topic from the NFL to the military—and certainly among parents of the 20 million American youths who play sports with concussion risk.

Harald Steltzer, CEO of NoMo Diagnostics, has set out to solve that. He's developing what he hopes will be the first FDA-approved, real-time concussion detector to facilitate early recognition and treatment. His technology monitors two brainwaves, which are strong enough to be measured outside the skull.

In addition to the undisclosed investment from Bats-Toi, NoMo Diagnostics received roughly $200,000 from the Coulter Foundation at Columbia University and $75,000 from the National Security Innovation Network.”